Dave Gentry Features Top 5 Healthcare Stocks for 2015 on This Week's RedChip Money Report on Fox Business and Bloomberg
GlobeNewswire - Tue Dec 16, 2:52PM CST
RedChip Companies, Inc. ("RedChip"
OPXA: 0.80 (+0.01), ATNM: 6.00 (-0.22), AKER: 3.20 (-0.10), CGIX: 7.12 (+0.06)
Insider Trading Alert - AMT, LNC And CGIX Traded By Insiders
at The Street - Tue Dec 16, 11:29AM CST
Stocks with insider trader activity include AMT, LNC and CGIX
AMT: 100.75 (+0.10), LNC: 58.58 (-0.10), CGIX: 7.12 (+0.06)
Cancer Genetics, Inc. Announces Appointment of Venkatadri Bobba to Cancer Genetics India's Board of Directors
GlobeNewswire - Tue Dec 16, 6:30AM CST
Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or "the Company"
CGIX: 7.12 (+0.06)
Insider Trading Alert - BYD, CGIX And AAWW Traded By Insiders
at The Street - Mon Dec 15, 10:00AM CST
Stocks with insider trader activity include BYD, CGIX and AAWW
AAWW: 48.52 (+0.17), BYD: 12.28 (+0.14), CGIX: 7.12 (+0.06)
Insider Trading Alert - CGIX, NBY And BIOA Traded By Insiders
at The Street - Fri Dec 12, 10:15AM CST
Stocks with insider trader activity include CGIX, NBY and BIOA
BIOA: 8.52 (+0.07), NBY: 0.65 (+0.02), CGIX: 7.12 (+0.06)
Insider Trading Alert - CDW, CGIX And RDNT Traded By Insiders
at The Street - Thu Dec 11, 12:15PM CST
Stocks with insider trader activity include CDW, CGIX and RDNT
RDNT: 9.41 (-0.08), CGIX: 7.12 (+0.06), CDW: 35.75 (+0.14)
Cancer Genetics (CGIX) Looks Good: Stock Rises 8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Dec 11, 8:25AM CST
Cancer Genetics (CGIX) was a big mover last session, with shares rising just over 8% on the day.
Q: 59.48 (+0.01), CRL: 63.59 (+0.33), ICLR: 52.66 (+0.72), CGIX: 7.12 (+0.06)
Cancer Genetics, Inc. Strengthens Clinical Trials Leadership Team With Hire of Rob Fannon as Vice President of Operations
GlobeNewswire - Wed Dec 10, 6:30AM CST
Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or "the Company"
CGIX: 7.12 (+0.06)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Dec 09, 11:45AM CST
BLUE: 88.76 (+3.23), SC: 20.09 (-0.19), ANV: 0.88 (+0.02), UTIW: 11.84 (+0.02), AKAO: 12.76 (-0.23), CLDN: 18.54 (+0.85), MZOR: 13.01 (-0.68), NBG: 1.95 (+0.06), TTI: 6.57 (unch), TPLM: 5.74 (-0.41), CGIX: 7.12 (+0.06), LCI: 42.29 (+1.79), SAVE: 75.68 (+1.52), PQ: 3.87 (+0.02), AFMD: 6.19 (+0.03), ENSV: 1.54 (-0.05), CTC: 0.76 (+0.03), CONN: 18.23 (+1.23), PDCE: 43.46 (-1.39), KPTI: 37.78 (+1.28)
Cancer Genetics, Inc. to Receive $530,000 Through New Jersey Technology Business Tax Program
GlobeNewswire - Tue Dec 09, 8:12AM CST
Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or "the Company"
CGIX: 7.12 (+0.06)
Cancer Genetics, Inc. Announces Launch of Targeted Next Generation Sequencing Based Panel for Chronic Lymphocytic Leukemia, Focus::CLL
GlobeNewswire - Mon Dec 08, 6:30AM CST
-- Only NGS-based panel for CLL that offers information for patient risk stratification, disease management, and treatment selection
CGIX: 7.12 (+0.06)
RedChip Receives Top Praise for Its Performance
GlobeNewswire - Thu Dec 04, 8:45AM CST
RedChip Companies, Inc. ("RedChip"
CGIX: 7.12 (+0.06)
Cancer Genetics Inc. Announces the Appointments of Dr. Howard McLeod and Geoffrey Harris to Its Board of Directors
GlobeNewswire - Wed Dec 03, 4:41PM CST
Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or the "Company"
CGIX: 7.12 (+0.06)
Cancer Genetics, Inc. to Present at 26th Annual Piper Jaffray Healthcare Conference
GlobeNewswire - Mon Dec 01, 6:55AM CST
Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or "the Company"
CGIX: 7.12 (+0.06)
Cancer Genetics, Inc. to Present at American Society of Hematology (ASH) Annual Meeting
GlobeNewswire - Mon Nov 17, 6:50AM CST
-- Cancer Genetics will present two posters on diffuse large B-cell lymphoma (DLBCL), the most common form of B-cell cancers.
CGIX: 7.12 (+0.06)
Cancer Genetics, Inc. Recognized in Deloitte's 2014 Technology Fast 500(TM) Awards
GlobeNewswire - Fri Nov 14, 7:06AM CST
Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or "the company"
CGIX: 7.12 (+0.06)
Cancer Genetics Inc to Present at Canaccord Genuity Medical Technology & Diagnostics Conference
GlobeNewswire - Thu Nov 13, 6:55AM CST
Cancer Genetics, Inc., (Nasdaq:CGIX) an emerging leader in DNA-based cancer diagnostics, announced today that the company's CEO, Panna Sharma, will present at the upcoming Canaccord Genuity Medical Technology & Diagnostics Conference. The event, which will be held at the Westin Grand Central in New York on Thursday, November 20, will profile over 80 public and private med-tech and diagnostic companies.
CGIX: 7.12 (+0.06)
Cancer Genetics wins second patent for FHACT test to improve cervical cancer detection for up to 2m women in the US each year
M2 - Wed Nov 12, 7:02AM CST
Cancer diagnostics company Cancer Genetics (NasdaqCM:CGIX) disclosed on Tuesday the receipt of the second US patent (US Patent No. 8,883,414) for its proprietary FISH-based HPV-Associated Cancer Test (FHACT) for cervical cancer detection in patients.
CGIX: 7.12 (+0.06)
RedChip Issues Research Note on Cancer Genetics
GlobeNewswire - Wed Nov 12, 7:00AM CST
RedChip Companies, Inc., today announced it has issued a research note on Cancer Genetics, Inc. (Nasdaq:CGIX), an emerging leader in DNA-based cancer diagnostics that personalizes the clinical management of difficult-to-diagnose cancers.
CGIX: 7.12 (+0.06)
Cancer Genetics Inc to Present on Company's Targeted Next-Generation Sequencing Panels at AMP
GlobeNewswire - Wed Nov 12, 6:55AM CST
Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or "the Company"
CGIX: 7.12 (+0.06)